Clinical Trial Update: Safety of LAIV4 in Children With Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the safety of LAIV4 in children with asthma; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Asthma in Children

Drugs mentioned

• LAIV4 (live attenuated influenza vaccine (quadrivalent))

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Asthma in Children, Vaccine Adverse Reaction | Phase 4 | Status: COMPLETED | Results posted: 2021-02-25